We are live on
!
Find out more
PAWC
P.A.W. Capital Portfolio holdings
AUM
$88.2M
1-Year Est. Return
25.13%
This Fund
S&P 500
This Quarter
Est. Return
+55.79%
1 Year Est. Return
+25.13%
3 Year Est. Return
+30.54%
5 Year Est. Return
+27.6%
10 Year Est. Return
+989.99%
AUM
$93.8M
AUM Growth
+$13.6M
(+17%)
Cap. Flow
-$4.61M
Cap. Flow
% of AUM
-4.92%
Top 10 Holdings %
Top 10 Hldgs %
41.34%
Holding
68
New
7
Increased
10
Reduced
25
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
OptimizeRx
OPRX
|
+$2.78M |
| 2 |
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
|
+$851K |
| 3 |
Spyre Therapeutics
SYRE
|
+$785K |
| 4 |
SIX
Six Flags Entertainment Corp.
SIX
|
+$736K |
| 5 |
Wells Fargo
WFC
|
+$629K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
+$1.44M |
| 2 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$1.2M |
| 3 |
Regenxbio
RGNX
|
+$1.19M |
| 4 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$1.12M |
| 5 |
EverQuote
EVER
|
+$780K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.13% |
| 2 | Healthcare | 25.68% |
| 3 | Communication Services | 15.38% |
| 4 | Consumer Staples | 9.73% |
| 5 | Financials | 5.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNST
1
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $5.18M | 5.53% |
110,000
-50,000
| -31% | -$1.44M |
|
2
Digital Turbine
APPS
$971M
| $4.63M | 4.94% |
650,000
-80,000
| -11% | -$595K |
|
|
VRTU
3
DELISTED
Virtusa Corporation
VRTU
| $4.53M | 4.83% |
100,000
-10,000
| -9% | -$408K |
|
|
CTLP
4
DELISTED
Cantaloupe
CTLP
| $4.07M | 4.34% |
550,000
+60,000
| +12% | +$444K |
|
|
RCM
5
DELISTED
R1 RCM Inc. Common Stock
RCM
| $3.89M | 4.15% |
300,000
-35,000
| -10% | -$400K |
|
|
APTO
6
DELISTED
Aptose Biosciences, Inc.
APTO
| $3.86M | 4.11% |
1,511
+400
| +36% | +$521K |
|
7
Allot
ALLT
$365M
| $3.4M | 3.63% |
400,000
-30,000
| -7% | -$246K |
|
8
Marchex
MCHX
$74M
| $3.21M | 3.43% |
850,000
-150,000
| -15% | -$539K |
|
9
Mitek Systems
MITK
$718M
| $3.06M | 3.26% |
400,000
| – | – |
|
|
10
OptimizeRx
OPRX
$117M
| $2.93M | 3.12% |
285,000
+245,000
| +613% | +$2.78M |
|
11
uniQure
QURE
$2.71B
| $2.87M | 3.06% |
40,000
-12,000
| -23% | -$659K |
|
12
Magnite
MGNI
$2.57B
| $2.86M | 3.05% |
350,000
-12,500
| -3% | -$103K |
|
13
Chegg
CHGG
$109M
| $2.84M | 3.03% |
75,000
| – | – |
|
|
14
EverQuote
EVER
$867M
| $2.58M | 2.75% |
75,000
-28,000
| -27% | -$780K |
|
15
Ambarella
AMBA
$3.09B
| $2.42M | 2.58% |
40,000
| – | – |
|
16
CareCloud
CCLD
$92.2M
| $2.42M | 2.58% |
595,000
+10,100
| +2% | +$39.9K |
|
|
ASPU
17
DELISTED
ASPEN GROUP, INC.
ASPU
| $2.4M | 2.56% |
300,000
| – | – |
|
18
Gaia
GAIA
$47.1M
| $2.2M | 2.34% |
275,000
| – | – |
|
|
EIGR
19
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $2.15M | 2.29% |
4,800
-1,867
| -28% | -$663K |
|
|
EMKR
20
DELISTED
Emcore Corp
EMKR
| $1.76M | 1.88% |
58,000
| – | – |
|
21
Varonis Systems
VRNS
$5.14B
| $1.55M | 1.66% |
60,000
| – | – |
|
|
QUOT
22
DELISTED
Quotient Technology Inc
QUOT
| $1.48M | 1.58% |
150,000
-40,000
| -21% | -$383K |
|
|
23
Regenxbio
RGNX
$656M
| $1.43M | 1.53% |
35,000
-30,000
| -46% | -$1.19M |
|
24
LendingTree
TREE
$550M
| $1.21M | 1.29% |
4,000
| – | – |
|
|
ORTX
25
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $963K | 1.03% |
+7,000
| New | +$851K |
|
Similar funds
MPEM
RFL
GBA
BLC
PBCM
PM
BCP
CVM
P.A.W. Capital's Q4 2019 Portfolio in Review
As of Q4 2019, P.A.W. Capital held 68 positions worth $93.8M, up 17% from $80.2M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
P.A.W. Capital withdrew a net $4.61M in Q4 2019, closing 7 positions and reducing 25 holdings. Its most notable exit was Mandiant, Inc. Common Stock, an estimated $1.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 34% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, P.A.W. Capital opened a new position in Orchard Therapeutics plc American Depositary Shares worth $963K.
- P.A.W. Capital's largest Q4 2019 buy was Orchard Therapeutics plc American Depositary Shares: 7,000 shares worth $963K.
- P.A.W. Capital added most to OptimizeRx in Q4 2019, an estimated $2.78M increase.
- P.A.W. Capital's biggest Q4 2019 reduction was Constellation Pharmaceuticals, Inc., cutting an estimated $1.44M.
- P.A.W. Capital fully exited Mandiant, Inc. Common Stock in Q4 2019, selling an estimated $1.2M.
- P.A.W. Capital's ten largest holdings make up 41% of its $93.8M portfolio in Q4 2019.
- P.A.W. Capital opened 7 new positions and closed 7 in Q4 2019.
- P.A.W. Capital's portfolio value rose 17% quarter-over-quarter to $93.8M.
Based on P.A.W. Capital's 13F filing for Q4 2019, filed 28 Jan 2020.